In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...

Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2026 following ...

Felix Health announced it will offer Galleri, GRAIL's multi-cancer early detection test, through its virtual care platform in the coming weeks, with access beginning for eligible patients in Ontario.

Freenome revealed SimpleScreen Lung and a pioneering combined test enabling eligible patients to undergo screening for both ...

A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...

Background The role of intrinsic tumour heterogeneity in driving organ-tropic metastasis in gastric cancer remains ...

Guardant Health's Shield blood test achieved 99% real-world adherence in two rural clinics, far exceeding typical 28-71% ...

The FDA is expected to approve a new kind of blood test that may allow earlier diagnosis and less invasive, more effective ...

Q: My spouse was recently diagnosed with a blood cancer, and we're overwhelmed by everything we’re being told. What should ...

Pope Leo XIV began walking and resumed eating after thoracic surgery at Rome's Gemelli Hospital, with blood tests and an ...

Even with 'Bad LDL 200,' I Don't Collapse—Fundamental Questions About Medicine Raised by 34 Years of Blood Tests……To Our ...